Paper published in a journal (Scientific congresses and symposiums)
#523 Initial efficacy and safety results from ENGOT-Ov60/GOG-3052/RAMP 201: a phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC)
Banerjee, Susana N; Ring, Kari L; Niewenhuysen, Els Vanet al.
2023 • In International Journal of Gynecological Cancer, 33, p. 20-A21
#523 Initial efficacy and safety results from ENGOT-Ov60/GOG-3052/RAMP 201: a phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC)
Publication date :
September 2023
Event name :
ESGO's 24th European Gynaecological Oncology Congress